Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections

Documenti analoghi

• Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
  di: Matsuo, SM, et al.
  Pubblicazione: (2011)
• Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
  di: Ikeda, T, et al.
  Pubblicazione: (2012)
• White blood cell counts have an impact on septic patient outcome followed by polymyxin-b immobilized fiber with direct hemoperfusion
  di: Tanaka, H, et al.
  Pubblicazione: (2015)
• Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
  di: Yamashita, C, et al.
  Pubblicazione: (2011)
• Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
  di: Kase, Y, et al.
  Pubblicazione: (2009)